Ameriprise Financial Inc. Buys Shares of 54,375 Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Ameriprise Financial Inc. acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 54,375 shares of the company’s stock, valued at approximately $248,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. KLP Kapitalforvaltning AS acquired a new position in shares of Aveanna Healthcare during the fourth quarter worth about $35,000. Tower Research Capital LLC TRC boosted its position in shares of Aveanna Healthcare by 662.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company’s stock worth $36,000 after buying an additional 6,854 shares during the period. Catalyst Funds Management Pty Ltd boosted its position in shares of Aveanna Healthcare by 321.4% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock worth $54,000 after buying an additional 9,000 shares during the period. Sagespring Wealth Partners LLC acquired a new position in shares of Aveanna Healthcare during the fourth quarter worth about $57,000. Finally, Walleye Capital LLC acquired a new position in shares of Aveanna Healthcare during the fourth quarter worth about $64,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $5.51 on Friday. The stock has a 50 day moving average price of $5.08 and a 200 day moving average price of $4.94. Aveanna Healthcare Holdings Inc. has a 52 week low of $2.32 and a 52 week high of $6.19. The stock has a market capitalization of $1.07 billion, a PE ratio of -16.21 and a beta of 2.03.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on AVAH shares. Truist Financial reduced their price target on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating for the company in a research report on Friday, April 11th. UBS Group increased their price target on Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a research report on Friday, May 9th.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 1,560,700 shares of the company’s stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $5.36, for a total value of $8,365,352.00. Following the sale, the insider now owns 29,640,756 shares in the company, valued at $158,874,452.16. This represents a 5.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder J.H. Whitney Equity Partners V sold 61,564 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $5.51, for a total value of $339,217.64. Following the completion of the sale, the insider now owns 1,453,948 shares in the company, valued at $8,011,253.48. This represents a 4.06% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,887,612 shares of company stock valued at $26,269,057. Insiders own 7.80% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.